Taihe Weiye Biotechnology Secures RMB 300 Million in Series A+ Financing to Expand Production
Chengdu Taihe Weiye Biotechnology Co., Ltd, a Chinese developer of protected amino acids drugs, has...
Finance
Bayer Faces Backlash After Bond Sale Preceding Late-Stage Pipeline Failure
German pharmaceutical giant Bayer (ETR: BAYN) is facing investor and analyst scrutiny following its issuance...
Beijing QL Biopharmaceutical Boosts Pipeline with RMB 200 Million Series B+ Round
Beijing QL Biopharmaceutical Co., Ltd., a Chinese biopharmaceutical company, has reportedly secured nearly RMB 200...
OrbusNeich Medical Group to Acquire Majority Stake in Indonesian Distributor PT Revass Utama Medika
OrbusNeich Medical Group Ltd (HKG: 6929), a Wholly Owned Foreign Enterprise (WOFE) specializing in vascular...
Broncus Medical and Hangzhou Norchant Terminate Licensing Agreement with Cancellation Fee
Broncus Medical Inc., (HKG: 2216) a provider of lung disease precision intervention solutions with operations...
AbbVie Sues to Protect Rinvoq from Generic Competition in the US Market
AbbVie (NYSE: ABBV) has initiated legal action in the US to safeguard its blockbuster drug...
Zhejiang Huanqing Medical Technology Secures Series A Financing for Heart Failure Innovations
Zhejiang Huanqing Medical Technology Co., Ltd, a Chinese specialist in heart failure solutions, has reportedly...
True Health Secures Over RMB 100 Million in Series B+ Financing for Surgical Robot Development
True Health, a Guangdong-based surgical robot developer backed by Gree Group, has reportedly raised over...
Bayer Halts Late-Stage Trial for Asundexian After Underperformance
Germany-headquartered Bayer (ETR: BAYN) announced the termination of a late-stage trial for its antithrombotic candidate...
Dizal Pharmaceutical and Wuxi Gaofa Investment to Establish Joint Venture for Auto-Immune Disease Treatments
China-based AstraZeneca (AZ, NASDAQ: AZN) spin-out, Dizal Pharmaceutical Co., Ltd (SHA: 688192), has entered into...
Asia Regenerative Medicine Secures Pre-Series A Financing for Bioartificial Organ Development
Shenzhen-based bioartificial organ developer, Asia Regenerative Medicine, has reportedly raised tens of millions of renminbi...
VIVA Biotech Holdings Secures Nearly USD 210 Million in Financing Round
China-based Contract Research Organization (CRO) VIVA Biotech Holdings (HKG: 1873) has announced the completion of...
Fosun Pharmaceutical’s US Subsidiary Partners with Treehill Partners for Clinical-Stage Investments
Fosun Pharmaceutical (Group) Co., Ltd (HKG: 2196; SHA: 600196) through its US subsidiary, Fosun Pharma...
WuXi Biologics’ Subsidiary WuXi XDC Lists on Hong Kong Stock Exchange
WuXi Biologics (HKG: 2269) has successfully spun off its conjugate drug-focused subsidiary, WuXi XDC Cayman...
PRECEDO Secures Over RMB 100 Million in Financing to Build Living Primary Cancer Cell Bank
PRECEDO, a leading cell engineering specialist headquartered in Hefei, has reportedly secured more than RMB...
Huadong Medicine Co., Ltd Secures Partnership and Commercial Rights for Yuyan’s Botulinum Toxin
China-based Huadong Medicine Co., Ltd (SHE: 000963) has entered into an equity investment and partnership...
Boehringer Ingelheim and Scottish Enterprise Co-Lead GBP 4.3M Seed Funding for Glox Therapeutics
Germany’s Boehringer Ingelheim, in collaboration with Scotland’s national economic development agency Scottish Enterprise, has co-led...
Beijing-Based Immupeutics Medicine Secures Tens of Millions in Pre-Series A+ Financing
Immupeutics Medicine, a Beijing-based developer in the field of tumor immunotherapy, has reportedly secured tens...
Merck Reports Q3 2023 Financial Results with Mixed Performance Across Segments
Germany-based Merck (ETR: MRK) has released its financial results for the third quarter of 2023,...
Sandoz Enters Euro Debt Market with $2.1 Billion Eurobond Issuance
Switzerland-based Sandoz (SWX: SDZ), a leader in the generics and biosimilars market, has successfully entered...